Sanjay Garg, PhD
Sanjay Garg, PhD is a Pharmtech editorial advisory board (EAB) member.
Sanjay Garg, PhD
Associate Professor,
Department of Pharmacy
University of Auckland
Sanjay Garg is associate professor and deputy head of the School of Pharmacy at the University of Auckland, New Zealand. He is also chief scientific officer of the newly established AnQual GLP laboratory. Garg's research interests are novel drug delivery systems with emphasis on microbicides and anticancer formulations, regulatory affairs, and pharmaceutical management.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
